- •Foreword
- •Preface
- •List of Contributors
- •Acknowledgments
- •Dedication
- •In Memorium
- •DEFINITIONS
- •EPIDEMIOLOGIC AND SOCIOECONOMIC ASPECTS OF THE GLAUCOMAS
- •RISK FACTORS
- •CLASSIFICATION OF THE GLAUCOMAS
- •REFERENCES
- •Aqueous humor formation
- •FUNCTION OF AQUEOUS HUMOR
- •ANATOMY OF THE CILIARY BODY
- •STRUCTURE
- •ULTRASTRUCTURE OF THE CILIARY PROCESSES
- •VASCULAR SUPPLY
- •MECHANISM OF AQUEOUS FORMATION
- •ULTRAFILTRATION
- •ACTIVE TRANSPORT
- •DIFFUSION
- •CHEMICAL COMPOSITION OF THE AQUEOUS HUMOR
- •THE BLOOD–AQUEOUS BARRIER
- •PRESSURE-DEPENDENT TECHNIQUES
- •Tonography
- •Suction cup
- •Perfusion
- •TRACER METHODS
- •Photogrammetry
- •Radiolabeled isotopes
- •Fluorescein
- •Fluoresceinated dextrans
- •Paraminohippurate
- •Iodide
- •FACTORS AFFECTING AQUEOUS HUMOR FORMATION
- •DIURNAL VARIATION
- •INTRAOCULAR PRESSURE/PSEUDOFACILITY
- •BLOOD FLOW TO THE CILIARY BODY
- •NEURAL CONTROL
- •HORMONAL EFFECTS
- •INTRACELLULAR REGULATORS
- •CLINICAL ASPECTS OF AQUEOUS HUMOR FORMATION
- •CLINICAL CONDITIONS
- •PHARMACOLOGIC AGENTS
- •SURGERY
- •REFERENCES
- •PHYSIOLOGY ISSUES UNIQUE TO THE CONVENTIONAL AQUEOUS OUTFLOW SYSTEM
- •FUNCTIONS OF THE CONVENTIONAL AQUEOUS OUTFLOW SYSTEM
- •ANATOMY OF THE CONVENTIONAL OUTFLOW SYSTEM
- •SCHWALBE’S LINE
- •SCLERAL SPUR
- •TRABECULAR MESHWORK TISSUES
- •Uveal meshwork
- •Corneoscleral meshwork
- •Uveal and corneoscleral meshwork ultrastructure
- •Juxtacanalicular space and cells
- •SCHLEMM’S CANAL
- •Overview
- •Schlemm’s canal inner wall endothelium
- •Glycocalyx
- •Distending cells that form invaginations or pseudovacuoles, ‘giant vacuoles’
- •Schlemm’s canal endothelium pores
- •Sonderman’s canals invaginate into the trabecular meshwork
- •Septa
- •Schlemm’s canal valves spanning across Schlemm’s canal
- •Herniations or protrusions of Schlemm’s canal inner wall
- •Collector channels, aqueous veins and episcleral veins
- •RESISTANCE SITES IN THE AQUEOUS OUTFLOW SYSTEM
- •JUXTACANALICULAR SPACE RESISTANCE
- •SCHLEMM’S CANAL ENDOTHELIUM RESISTANCE
- •PRINCIPLES OF BIOMECHANICS AS A METHODOLOGY TO IDENTIFY TISSUE RESISTANCE
- •TISSUE LOADING STUDIES
- •BOUNDARY CONDITIONS
- •EVIDENCE FROM EXPERIMENTAL MICROSURGERY
- •AQUEOUS OUTFLOW PHYSIOLOGY: PASSIVE AND DYNAMIC FLOW MODELS
- •THE AQUEOUS OUTFLOW SYSTEM AS A PASSIVE FILTER
- •THE AQUEOUS OUTFLOW SYSTEM AS A DYNAMIC MECHANICAL PUMP
- •EXTRINSIC PRESSURE REGULATION MECHANISMS
- •UVEOSCLERAL FLOW
- •METHODS FOR MEASURING FACILITY OF OUTFLOW
- •FACILITY OF OUTFLOW CALCULATIONS
- •Tonography
- •Perfusion
- •Suction cup
- •FACILITY OF OUTFLOW AND ITS CLINICAL IMPLICATIONS
- •FACTORS AFFECTING THE FACILITY OF OUTFLOW
- •HORMONES
- •CILIARY MUSCLE TONE
- •DRUGS
- •SURGICAL THERAPY
- •DIURNAL FLUCTUATION
- •GLAUCOMA
- •EPISCLERAL VENOUS PRESSURE
- •REFERENCES
- •Intraocular pressure
- •INSTRUMENTS FOR MEASURING INTRAOCULAR PRESSURE
- •APPLANATION INSTRUMENTS
- •Goldmann tonometer
- •Perkins tonometer
- •Draeger tonometer
- •MacKay-Marg and Tono-Pen™ tonometers
- •Pneumatic tonometer
- •Non-contact tonometer
- •The Ocuton™ tonometer
- •Maklakow tonometer
- •INDENTATION INSTRUMENTS
- •Schiøtz tonometer
- •Electronic Schiøtz tonometer
- •Impact–rebound tonometer
- •Transpalpebral tonometry
- •DYNAMIC CONTOUR TONOMETRY
- •CONTINUOUS MONITORING OF INTRAOCULAR PRESSURE
- •SUMMARY OF TONOMETRY
- •DISTRIBUTION OF INTRAOCULAR PRESSURE IN THE GENERAL POPULATION
- •FACTORS THAT INFLUENCE INTRAOCULAR PRESSURE
- •RACE
- •HEREDITY
- •DIURNAL VARIATION
- •SEASONAL VARIATION
- •CARDIOVASCULAR FACTORS
- •EXERCISE
- •WIND INSTRUMENT PLAYING
- •LIFESTYLE
- •POSTURAL CHANGES
- •NEURAL FACTORS
- •PSYCHIATRIC DISORDERS
- •HORMONAL FACTORS
- •REFRACTIVE ERROR
- •FOODS AND DRUGS
- •MISCELLANEOUS
- •EYE MOVEMENTS
- •EYELID CLOSURE
- •INFLAMMATION
- •SURGERY
- •REFERENCES
- •Gonioscopic anatomy
- •GROSS ANATOMY
- •ANATOMIC FEATURES OF NORMAL EYES
- •GONIOSCOPIC ANATOMY AND MICROSCOPIC INTERPRETATION
- •PUPIL AND IRIS
- •CILIARY BODY, IRIS PROCESSES, AND SYNECHIAE
- •SCLERAL SPUR
- •SCHWALBE’S LINE
- •TRABECULAR MESHWORK AND TRABECULAR PIGMENT BAND
- •GONIOSCOPIC APPEARANCE
- •REFERENCES
- •Methods of gonioscopy
- •DEFINITION
- •METHODS OF GONIOSCOPY
- •EQUIPMENT
- •Goldmann and Zeiss lenses (indirect method)
- •Koeppe lens (direct method)
- •TECHNIQUE
- •Indirect gonioscopic lenses
- •Indentation (compression) gonioscopy
- •Direct gonioscopic lens
- •REFERENCES
- •GRADING OF CHAMBER ANGLE
- •DIAGRAMMING ANGLE WIDTH, SYNECHIAE, AND PIGMENTATION
- •TRABECULAR PIGMENT BAND
- •SPAETH CLASSIFICATION
- •STEP 4: TRABECULAR MESHWORK PIGMENTATION
- •EXAMPLES
- •DIFFICULTIES AND ARTIFACTS IN GONIOSCOPY
- •CLINICAL USEFULNESS OF GONIOSCOPY
- •AID IN DIAGNOSIS OF TYPE OF GLAUCOMA
- •EVALUATION OF SYMPTOMS
- •USE OF DRUGS
- •POSTOPERATIVE EXAMINATIONS
- •CONDITIONS OTHER THAN GLAUCOMA
- •SUMMARY OF IMPORTANT GONIOSCOPIC TECHNIQUES
- •REFERENCES
- •APPENDIX
- •Visual field theory and methods
- •THE NORMAL VISUAL FIELD
- •VISUAL ACUITY VERSUS VISUAL FIELD
- •TERMINOLOGY AND DEFINITIONS
- •THEORY OF VISUAL FIELD TESTING
- •KINETIC PERIMETRY
- •STATIC PERIMETRY
- •THRESHOLD-RELATED TESTING
- •ZONE TESTING
- •SCREENING TESTS
- •OTHER STATIC TESTING TECHNIQUES
- •THE FUTURE OF VISUAL FIELD TESTING
- •COMBINED STATIC AND KINETIC PERIMETRY
- •REFERENCES
- •PATIENT VARIABLES
- •FIXATION
- •RELIABILITY
- •OCULAR VARIABLES
- •PUPIL SIZE
- •MEDIA CLARITY
- •REFRACTIVE CORRECTION
- •TESTING VARIABLES
- •TECHNICIAN
- •BACKGROUND ILLUMINATION
- •STIMULUS SIZE AND INTENSITY
- •STIMULUS EXPOSURE TIME
- •AREA TESTED
- •EQUIPMENT AND TECHNIQUES
- •GENERAL PRINCIPLES
- •TANGENT SCREEN
- •BOWL PERIMETRY
- •Preparing the patient
- •Technique of computerized bowl perimetry
- •REFERENCES
- •Visual field interpretation
- •GLAUCOMATOUS CHANGES IN THE VISUAL FIELD
- •ANATOMY OF VISUAL FIELD DEFECTS
- •TYPES OF VISUAL FIELD LOSS
- •Generalized loss
- •Localized defects (scotomata)
- •GLAUCOMATOUS VISUAL FIELD DEFECTS
- •Generalized depression
- •Irregularity of the visual field
- •Nasal step or depression
- •Temporal step or depression
- •Enlargement of the blind spot
- •Isolated paracentral scotomata
- •Arcuate defects (nerve fiber bundle defects)
- •End-stage defects
- •Central and temporal islands
- •Reversal of visual field defects
- •ANALYSIS OF VISUAL FIELD LOSS
- •CHRONIC OPEN-ANGLE GLAUCOMA
- •ANGLE-CLOSURE GLAUCOMA
- •OTHER CAUSES
- •ESTERMAN DISABILITY RATING
- •ANALYSIS OF COMPUTERIZED STATIC PERIMETRY
- •RELIABILITY INDEXES
- •False-positive and false-negative responses
- •Fixation reliability
- •FLUCTUATION
- •Short-term fluctuation
- •Long-term fluctuation
- •GLOBAL INDEXES
- •Mean sensitivity
- •Mean deviation or defect
- •Standard deviation or variance
- •GRAPHIC PLOTS
- •AREA OF THE VISUAL FIELD TO BE TESTED
- •LONG-TERM ANALYSIS
- •DETERMINATION OF NORMAL VISUAL FIELD
- •DEVIATION FROM NORMAL VALUES
- •Graphic plot of points varying from normal
- •Global indexes
- •Comparison with the other eye
- •Localized variation within the visual field
- •RECOGNITION OF CHANGE
- •QUANTIFYING VISUAL FIELD CHANGE
- •THE FUTURE OF COMPUTERIZED PERIMETRY
- •REFERENCES
- •Other psychophysical tests
- •INTRODUCTION
- •COLOR VISION AND SHORT-WAVELENGTH AUTOMATED PERIMETRY
- •FREQUENCY-DOUBLING PERIMETRY
- •OTHER PSYCHOPHYSICAL TESTS
- •HIGH-PASS RESOLUTION PERIMETRY
- •MOTION DETECTION PERIMETRY
- •ELECTROPHYSIOLOGY
- •The electroretinogram (ERG)
- •The pattern electroretinogram (PERG)
- •The multifocal electroretinogram (mfERG)
- •The multifocal visual-evoked potential (mfVEP)
- •REFERENCES
- •ANATOMY OF THE OPTIC NERVE HEAD
- •WHERE ARE THE GANGLION CELLS INJURED?
- •WHAT INJURES GANGLION CELLS?
- •Ganglion Cell Susceptibility
- •Connective tissue structures within the optic nerve head
- •Vascular nutrition of the optic disc
- •REFERENCES
- •CLINICAL TECHNIQUES OF EVALUATION
- •OPTIC DISC CHANGES IN GLAUCOMA
- •INTRAPAPILLARY DISC CHANGES
- •Optic disc size
- •Optic disc shape
- •Neuroretinal rim size (NRR)
- •Neuroretinal rim shape
- •Optic cup size in relation to optic disc size
- •Optic cup configuration and depth
- •Cup:disc ratios
- •Position of central retinal vessels and branches
- •PERIPAPILLARY DISC CHANGES
- •Optic disc hemorrhages
- •Nerve fiber layer defects
- •Diameter of retinal arterioles
- •Peripapillary choroidal atrophy
- •PATTERNS OF OPTIC NERVE CHANGES AND SUBTYPES OF GLAUCOMA
- •HIGH MYOPIA DISC PATTERN
- •FOCAL NORMAL-PRESSURE PATTERN (FOCAL ISCHEMIC)
- •AGE-RELATED ATROPHIC PRIMARY OPEN-ANGLE GLAUCOMA PATTERN (SENILE SCLEROTIC)
- •JUVENILE OPEN-ANGLE GLAUCOMA PATTERN
- •PRIMARY OPEN-ANGLE GLAUCOMA PATTERN (GENERALIZED ENLARGEMENT)
- •REFERENCES
- •Optic nerve imaging
- •CONFOCAL SCANNING LASER OPHTHALMOSCOPY (CSLO)
- •HEIDELBERG RETINA TOMOGRAPHY (HRT)
- •Components of the HRT report
- •Evaluating scan quality
- •Strengths and limitations
- •New developments
- •Testing from the patient’s perspective
- •OPTICAL COHERENCE TOMOGRAPHY (OCT)
- •DIFFERENT SCANNING MODALITIES
- •Peripapillary scan
- •Macular scan
- •ONH scan
- •Fast scans
- •COMPONENTS OF THE OCT REPORT
- •RNFL thickness average analysis
- •Macular analysis
- •Optic nerve head analysis
- •QUALITY ASSESSMENT
- •STRENGTHS AND LIMITATIONS
- •TESTING FROM THE PATIENT’S PERSPECTIVE
- •LONGITUDINAL EVALUATIONS
- •SCANNING LASER POLARIMETRY
- •Components of the GDX report
- •Quality assessment
- •Strengths and limitations
- •Testing from the patient’s perspective
- •CONCLUSIONS
- •REFERENCES
- •Primary angle-closure glaucoma
- •HISTORICAL REVIEW AND CLASSIFICATIONS
- •CLASSIFICATIONS OF ANGLE-CLOSURE DISEASE
- •TWENTY-FIRST CENTURY CONSENSUS CLASSIFICATION
- •CLARIFICATIONS AND COMMENTARY
- •PRESENTATIONS OF PRIMARY ANGLE-CLOSURE DISEASE
- •NEW IMAGING TECHNOLOGIES
- •CLASSIFICATION BY MECHANISMS IN THE ANTERIOR SEGMENT
- •PUPILLARY BLOCK GLAUCOMA
- •Epidemiologic studies
- •Demographic risk factors
- •Gender
- •Heredity
- •Refractive error
- •Miscellaneous factors
- •Ocular risk factors and mechanisms
- •Iris bowing and lens–iris channel
- •Provocative tests
- •Clinical presentations of acute PACG with pupillary block
- •Signs and symptoms
- •Clinical examination
- •Treatment of acute PACG
- •Medical management of acute PACG
- •Slit-lamp maneuvers in management of acute PACG
- •Laser interventions for acute PACG
- •Surgical management of PACG
- •Management of the fellow eye
- •Sequelae of acute PACG
- •Correlating older and newer terminologies for angle closure
- •PLATEAU IRIS
- •Plateau iris configuration
- •Plateau iris syndrome
- •Pseudoplateau iris (cysts of the iris and ciliary body)
- •PHACOMORPHIC GLAUCOMA
- •Intumescent and swollen lens
- •REFERENCES
- •OVERVIEW OF TERMS AND MECHANISMS
- •ANTERIOR PULLING MECHANISM
- •NEOVASCULAR GLAUCOMA
- •Histopathology
- •Pathogenesis
- •Conditions and diseases commonly associated with neovascular glaucoma
- •Diabetes mellitus
- •Central retinal vein occlusion
- •Carotid occlusive disease
- •Ocular ischemic syndrome
- •Central retinal artery occlusion
- •Miscellaneous
- •Clinical presentation
- •Treatment
- •IRIDOCORNEAL ENDOTHELIAL SYNDROME
- •Histopathology
- •Pathogenesis
- •Clinical presentation
- •Progressive (essential) iris atrophy
- •Chandler’s syndrome
- •Cogan-Reese syndrome
- •Treatment
- •POSTERIOR POLYMORPHOUS DYSTROPHY
- •Histopathology
- •Pathogenesis
- •Clinical presentation
- •Treatment
- •EPITHELIAL DOWNGROWTH
- •Pathophysiology
- •Histopathology
- •Clinical presentation
- •Treatment
- •FIBROVASCULAR INGROWTH
- •FLAT ANTERIOR CHAMBER
- •INFLAMMATION
- •PENETRATING KERATOPLASTY
- •IRIDOSCHISIS
- •ANIRIDIA
- •POSTERIOR PUSHING (OR ROTATIONAL) MECHANISM
- •CILIARY BLOCK GLAUCOMA (AQUEOUS MISDIRECTION OR MALIGNANT GLAUCOMA)
- •INTRAOCULAR TUMORS
- •NANOPHTHALMOS
- •SUPRACHOROIDAL HEMORRHAGE
- •POSTERIOR SEGMENT INFLAMMATORY DISEASE
- •Treatment
- •CENTRAL RETINAL VEIN OCCLUSION
- •SCLERAL BUCKLING PROCEDURE
- •PANRETINAL PHOTOCOAGULATION
- •RETINOPATHY OF PREMATURITY
- •PUPILLARY BLOCK MECHANISMS
- •Secondary pupillary block glaucoma: iris–lens adhesions
- •Dislocated and subluxed lens
- •Ectopia lentis
- •Microspherophakia
- •REFERENCES
- •Primary open angle glaucoma
- •EPIDEMIOLOGY
- •PREVALENCE
- •PATHOPHYSIOLOGY
- •DIMINISHED AQUEOUS HUMOR OUTFLOW FACILITY
- •Altered corticosteroid metabolism
- •Dysfunctional adrenergic control
- •Abnormal immunologic processes
- •Oxidative damage
- •Other toxic influences
- •OPTIC NERVE CUPPING AND ATROPHY
- •CLINICAL FEATURES
- •FINDINGS
- •DIFFERENTIAL DIAGNOSIS
- •TREATMENT
- •INDICATIONS
- •GOALS
- •Target pressure
- •TYPES OF TREATMENT
- •PROGNOSIS
- •THE GLAUCOMA SUSPECT AND OCULAR HYPERTENSION
- •EPIDEMIOLOGY OF OCULAR HYPERTENSION
- •RISK FACTORS FOR DEVELOPMENT OF OPEN-ANGLE GLAUCOMA
- •TREATMENT
- •NORMAL-TENSION GLAUCOMA
- •PATHOGENESIS
- •CLINICAL FEATURES
- •DIFFERENTIAL DIAGNOSIS
- •WORK-UP
- •TREATMENT
- •REFERENCES
- •Secondary open angle glaucoma
- •PIGMENTARY GLAUCOMA
- •EXFOLIATION SYNDROME (PSEUDOEXFOLIATION SYNDROME)
- •CORTICOSTEROID GLAUCOMA
- •LENS-INDUCED GLAUCOMA
- •PHACOLYTIC GLAUCOMA
- •LENS-PARTICLE GLAUCOMA
- •PHACOANAPHYLAXIS
- •GLAUCOMA AFTER CATARACT SURGERY
- •GLAUCOMA FROM VISCOELASTIC SUBSTANCES
- •GLAUCOMA WITH PIGMENT DISPERSION FROM INTRAOCULAR LENSES
- •UVEITIS-GLAUCOMA-HYPHEMA SYNDROME
- •GLAUCOMA FROM VITREOUS IN THE ANTERIOR CHAMBER
- •GLAUCOMA AFTER TRAUMA
- •CHEMICAL BURNS
- •ELECTRIC SHOCK
- •RADIATION
- •PENETRATING INJURIES
- •CONTUSION INJURIES
- •GLAUCOMA ASSOCIATED WITH INTRAOCULAR HEMORRHAGE
- •GHOST-CELL GLAUCOMA
- •HEMOLYTIC GLAUCOMA
- •HEMOSIDEROSIS
- •HYPHEMA
- •RETINAL DETACHMENT AND GLAUCOMA
- •SCHWARTZ SYNDROME
- •GLAUCOMA AFTER VITRECTOMY
- •GLAUCOMA WITH UVEITIS
- •FUCHS’ HETEROCHROMIC IRIDOCYCLITIS
- •GLAUCOMATOCYCLITIC CRISIS
- •HERPES SIMPLEX
- •HERPES ZOSTER
- •SARCOIDOSIS
- •JUVENILE RHEUMATOID ARTHRITIS
- •SYPHILIS
- •INTRAOCULAR TUMORS AND GLAUCOMA
- •AMYLOIDOSIS
- •ELEVATED EPISCLERAL VENOUS PRESSURE
- •SUPERIOR VENA CAVA OBSTRUCTIONS
- •THYROID EYE DISEASE
- •ARTERIOVENOUS FISTULAS
- •STURGE-WEBER SYNDROME
- •IDIOPATHIC ELEVATIONS
- •REFERENCES
- •TERMINOLOGY
- •CLASSIFICATION
- •SYNDROME CLASSIFICATION
- •PRIMARY GLAUCOMA
- •CLINICAL ANATOMIC CLASSIFICATION
- •Isolated trabeculodysgenesis
- •Iridodysgenesis
- •Anterior stromal defects
- •Structural iris defects
- •Corneodysgenesis
- •CLINICAL PRESENTATION
- •EXAMINATION
- •Office examination
- •Examination under anesthesia
- •Intraocular pressure measurement
- •Corneal measurements: diameter and central thickness
- •Axial length measurement
- •Gonioscopy
- •Ophthalmoscopy
- •Cycloplegic refraction
- •Systemic evaluation
- •PRIMARY CONGENITAL GLAUCOMA
- •INCIDENCE
- •GENETICS AND HEREDITY
- •PATHOPHYSIOLOGY
- •DIFFERENTIAL DIAGNOSIS
- •Other glaucomas
- •Other causes of corneal enlargement or clouding
- •Other causes of epiphora or photophobia
- •Other optic nerve abnormalities
- •MANAGEMENT
- •Preoperative management
- •Initial surgery
- •Follow-up evaluations
- •Filtering surgery
- •Synthetic drainage devices
- •Cyclodestructive procedures
- •Long-term follow-up, management, and prognosis
- •Late developing primary congenital glaucoma
- •GLAUCOMA ASSOCIATED WITH OTHER CONGENITAL ANOMALIES
- •FAMILIAL HYPOPLASIA OF THE IRIS WITH GLAUCOMA
- •DEVELOPMENTAL GLAUCOMA WITH ANOMALOUS SUPERFICIAL IRIS VESSELS
- •ANIRIDIA
- •STURGE-WEBER SYNDROME (ENCEPHALOFACIAL ANGIOMATOSIS, ENCEPHALOTRIGEMINAL ANGIOMATOSIS)
- •NEUROFIBROMATOSIS (VON RECKLINGHAUSEN’S DISEASE)
- •PIERRE ROBIN AND STICKLER SYNDROMES
- •SKELETAL DYSPLASTIC SYNDROMES
- •CORNEODYSGENESIS
- •Axenfeld’s anomaly
- •Rieger’s anomaly and syndrome
- •PETER’S ANOMALY
- •LOWE SYNDROME (OCULOCEREBRORENAL SYNDROME)
- •MICROCORNEA SYNDROMES
- •RUBELLA
- •CHROMOSOME ABNORMALITIES
- •BROAD THUMB SYNDROME (RUBENSTEIN–TAYBI SYNDROME)
- •SECONDARY GLAUCOMA IN INFANTS
- •PERSISTENT FETAL VASCULATURE (PERSISTENT HYPERPLASITIC PRIMARY VITREOUS)
- •RETINOPATHY OF PREMATURITY (RETROLENTAL FIBROPLASIAS)
- •LENS-RELATED GLAUCOMAS
- •Aphakic pediatric glaucoma
- •Subluxation and pupillary block
- •Marfan syndrome
- •Homocystinuria
- •Spherophakia and pupillary block
- •Weill-Marchesani and GEMSS syndromes
- •TUMORS
- •Retinoblastoma
- •Juvenile xanthogranuloma
- •INFLAMMATION
- •Juvenile rheumatoid arthritis
- •STEROID GLAUCOMA IN CHILDREN
- •NEOVASCULAR GLAUCOMA
- •TRAUMA
- •REFERENCES
- •Genetics of glaucoma
- •BASIC GENETICS
- •GENETIC NOMENCLATURE
- •PRIMARY OPEN-ANGLE, NORMAL-TENSION, AND JUVENILE-ONSET OPEN-ANGLE GLAUCOMA
- •TIGR/MYOCILIN
- •OPTINEURIN
- •OTHER GENES IN OPEN-ANGLE GLAUCOMA
- •EXFOLIATION SYNDROME AND GLAUCOMA
- •GLAUCOMA ASSOCIATED WITH DEVELOPMENTAL DISORDERS
- •PRIMARY CONGENITAL GLAUCOMA
- •AXENFELD-RIEGER ANOMALY
- •ANIRIDIA
- •NAIL PATELLA SYNDROME
- •RENAL TUBULAR ACIDOSIS
- •SUMMARY
- •REFERENCES
- •DIAGNOSIS
- •IDENTIFYING GLAUCOMA SUSPECTS
- •DETERMINING ADEQUACY OF TREATMENT
- •TREATMENT FOLLOW-UP
- •DOCUMENTATION OF PROGRESS
- •PATIENT EDUCATION
- •EFFECTIVE JUDGMENT
- •REFERENCES
- •TARGET PRESSURE
- •MEDICAL THERAPY
- •ADVANTAGES
- •DISADVANTAGES
- •SURGICAL THERAPY
- •ADVANTAGES
- •DISADVANTAGES
- •BASIC PHARMACOLOGY
- •BIOAVAILABILITY OF TOPICAL OCULAR MEDICATION
- •TEAR FILM
- •CORNEAL BARRIERS
- •DRUG FORMULATION
- •DRUG ELIMINATION
- •COMPLIANCE
- •GENERAL SUGGESTIONS FOR MEDICAL TREATMENT OF GLAUCOMA
- •ESTABLISH A TARGET PRESSURE
- •ADJUST THE TREATMENT PROGRAM TO THE PATIENT AND HIS OR HER LIFESTYLE
- •WHEN THERAPY IS INEFFECTIVE, SUBSTITUTE RATHER THAN ADD DRUGS
- •CONTINUALLY MONITOR THE TARGET PRESSURE
- •ASK ABOUT AND MONITOR OCULAR AND SYSTEMIC SIDE EFFECTS
- •SIMPLIFY AND REDUCE TREATMENT WHEN POSSIBLE
- •TEACH PATIENTS THE PROPER TECHNIQUE FOR INSTILLING EYEDROPS
- •PROVIDE WRITTEN INSTRUCTIONS
- •COMMUNICATE WITH THE PATIENT’S FAMILY PHYSICIAN
- •ASK ABOUT PROBLEMS WITH THE MEDICAL REGIMEN
- •CONSIDER DEFAULTING AS AN EXPLANATION FOR THE FAILURE OF MEDICAL TREATMENT
- •EDUCATE PATIENTS ABOUT THEIR ILLNESS AND ITS TREATMENT
- •STOP TREATMENT PERIODICALLY TO DETERMINE CONTINUING EFFECTIVENESS
- •MEASURE INTRAOCULAR PRESSURE AT DIFFERENT TIMES OF THE DAY AND AT DIFFERENT INTERVALS AFTER THE LAST ADMINISTRATION OF MEDICATION
- •RECOMMEND COMPARISON SHOPPING FOR MEDICATIONS
- •SUMMARY
- •REFERENCES
- •Prostaglandins
- •MECHANISM OF ACTION
- •DRUGS IN CLINICAL USE
- •LATANOPROST (XALATAN, PHXA41)
- •BIMATOPROST
- •TRAVOPROST
- •FIXED COMBINATION AGENTS
- •SIDE EFFECTS
- •SUGGESTIONS FOR USE
- •REFERENCES
- •MECHANISM(S) OF ACTION
- •EPINEPHRINE
- •DIPIVEFRIN
- •NOREPINEPHRINE
- •Phenylephrine
- •Clonidine
- •Apraclonidine
- •Brimonidine
- •Isoproterenol
- •Salbutamol
- •Others
- •DOPAMINERGIC AGONISTS
- •ADRENERGIC POTENTIATORS
- •MONOAMINE OXIDASE AND CATECHOL O-METHYLTRANSFERASE INHIBITORS
- •6-HYDROXYDOPAMINE
- •PROTRIPTYLINE
- •GUANETHIDINE (ISMELIN)
- •NONADRENERGIC ACTIVATORS OF ADENYLATE CYCLASE
- •DRUGS IN CLINICAL USE
- •Epinephrine (Eppy, Epinal, Epifrin, and generics)
- •Dipivefrin (Propine and generics)
- •Suggestions for use
- •Side effects
- •Clonidine
- •Prophylaxis in anterior segment laser surgery
- •Argon laser trabeculoplasty
- •Laser iridotomy
- •Nd:YAG laser posterior capsulotomy
- •Management of acute pressure rises
- •Management of open-angle and other chronic glaucomas
- •Combination therapy
- •Side effects
- •Suggestions for use
- •SUMMARY
- •REFERENCES
- •Adrenergic antagonists
- •MECHANISM OF ACTION
- •DRUGS IN CLINICAL USE
- •TIMOLOL MALEATE
- •TIMOLOL HEMIHYDRATE
- •BETAXOLOL
- •LEVOBUNOLOL
- •CARTEOLOL
- •METIPRANOLOL
- •PROPRANOLOL
- •ATENOLOL
- •PINDOLOL
- •NADOLOL
- •METAPROLOL
- •LABETOLOL
- •SUGGESTIONS FOR USE
- •OPEN-ANGLE GLAUCOMA
- •ANGLE-CLOSURE GLAUCOMA
- •SECONDARY GLAUCOMA
- •GLAUCOMA IN CHILDREN
- •BLOOD FLOW AND NEUROPROTECTION
- •SIDE EFFECTS
- •OCULAR
- •SYSTEMIC
- •OTHER ADRENERGIC ANTAGONISTS
- •Thymoxamine
- •Dapiprazole
- •Bunazosin
- •Prazosin
- •Others
- •REFERENCES
- •Carbonic anhydrase inhibitors
- •MECHANISM OF ACTION
- •DIRECT EFFECT ON AQUEOUS HUMOR FORMATION
- •INDIRECT EFFECT ON AQUEOUS HUMOR FORMATION
- •DRUGS IN CLINICAL USE
- •TOPICAL CARBONIC ANHYDRASE INHIBITORS
- •Dorzolamide
- •Brinzolamide
- •SYSTEMIC CARBONIC ANHYDRASE INHIBITORS
- •Acetazolamide
- •Methazolamide
- •Ethoxzolamide
- •Dichlorphenamide
- •SIDE EFFECTS
- •TOPICAL CARBONIC ANHYDRASE INHIBITORS
- •ORAL CARBONIC ANHYDRASE INHIBITORS
- •CONTRAINDICATIONS
- •Acidosis and sickling of red blood cells
- •Other severe symptoms
- •Retinal-choroidal blood flow and neuroprotection
- •SUGGESTIONS FOR USE
- •ANGLE-CLOSURE GLAUCOMA
- •OPEN-ANGLE GLAUCOMA
- •SECONDARY GLAUCOMA
- •INFANTILE AND JUVENILE GLAUCOMA
- •OTHER USES
- •REFERENCES
- •Cholinergic drugs
- •MECHANISMS OF ACTION
- •ANGLE-CLOSURE GLAUCOMA
- •OPEN-ANGLE GLAUCOMA
- •DRUGS IN CLINICAL USE
- •DIRECT-ACTING CHOLINERGIC AGENTS
- •Acetylcholine
- •Pilocarpine
- •Alternative drug delivery systems
- •Methacholine (Mecholyl)
- •Carbachol
- •Aceclidine (Glaucostat)
- •INDIRECT (ANTICHOLINESTERASE) AGENTS
- •Echothiophate iodide (phospholine iodide)
- •Demecarium bromide (Humorsol, Tosmilen)
- •Isoflurophate (Floropryl, di-isopropyl fluorophosphate, Dyflos)
- •Physostigmine (eserine)
- •Neostigmine (prostigmine)
- •SIDE EFFECTS
- •OCULAR
- •SYSTEMIC
- •SUGGESTIONS FOR USE
- •EXAMINATION
- •CONTRAINDICATIONS
- •REFERENCES
- •Hyperosmotic agents
- •MECHANISMS OF ACTION
- •DRUGS IN CLINICAL USE
- •ORAL AGENTS
- •Glycerol
- •Isosorbide
- •Ethyl alcohol
- •INTRAVENOUS AGENTS
- •Mannitol
- •Urea
- •SIDE EFFECTS
- •SUGGESTIONS FOR CLINICAL USE
- •ANGLE-CLOSURE GLAUCOMA
- •SECONDARY GLAUCOMA
- •CILIARY BLOCK (MALIGNANT) GLAUCOMA
- •TOPICAL HYPEROSMOTIC AGENTS
- •OTHER
- •REFERENCES
- •General aspects of laser therapy
- •GENERAL ASPECTS OF LASER THERAPY
- •TISSUE EFFECTS OF LASER
- •THERMAL EFFECTS (PHOTOCOAGULATION, PHOTOVAPORIZATION)
- •PHOTODISRUPTION
- •PHOTOABLATION
- •PHOTOCHEMICAL EFFECTS
- •GENERAL PREPARATION OF THE PATIENT
- •BASIC LASER SAFETY
- •REFERENCES
- •LASER PERIPHERAL IRIDOTOMY
- •INDICATIONS
- •TYPES OF LASER
- •GENERAL PREPARATION
- •ND:YAG LASER IRIDOTOMY
- •ARGON OR SOLID-STATE LASER IRIDOTOMY
- •LIGHT BROWN IRIS
- •Dark brown iris
- •Light blue iris
- •COMPLICATIONS OF LASER IRIDOTOMY
- •Iritis
- •Pressure elevation
- •Cataract
- •Hyphema
- •Corneal epithelial injury
- •Endothelial damage
- •Corneal stroma
- •Failure to perforate
- •Late closure
- •Retinal burn
- •Aphakia and pseudophakia with pupillary block
- •LASER IRIDOPLASTY (GONIOPLASTY)
- •PLATEAU IRIS
- •NANOPHTHALMOS
- •LASERS IN MALIGNANT GLAUCOMA
- •REFERENCES
- •LASER TRABECULOPLASTY
- •HISTORY
- •RESULTS
- •SELECTIVE LASER TRABECULOPLASTY
- •Concept
- •Mechanism
- •Technique
- •Patient preparation
- •Procedure
- •POSTOPERATIVE TREATMENT
- •OUTCOMES
- •CONTRAINDICATIONS
- •AS INITIAL THERAPY
- •PREDICTORS OF OUTCOME
- •APHAKIC AND PSEUDOPHAKIC OPEN-ANGLE GLAUCOMA
- •COMPLICATIONS
- •Intraocular pressure elevation
- •Sustained intraocular pressure increase
- •Hyphema
- •Peripheral anterior synechiae
- •Iritis
- •Uveitis
- •EXCIMER LASER TRABECULOSTOMY
- •Concept
- •Technique
- •Outcomes
- •OTHER LASER SCLEROSTOMY TECHNIQUES
- •REFERENCES
- •CYCLOPHOTOCOAGULATION
- •OTHER LASER PROCEDURES
- •SEVERING OF SUTURES
- •REOPENING FAILED FILTRATION SITES
- •CYCLODIALYSIS AND LASER
- •LASER SYNECHIALYSIS
- •GONIOPHOTOCOAGULATION
- •PHOTOMYDRIASIS (PUPILLOPLASTY)
- •REFERENCES
- •General surgical care
- •THE SURGICAL DECISION
- •PREOPERATIVE CARE
- •INSTRUCTIONS TO THE PATIENT
- •OUTPATIENT VERSUS INPATIENT SURGERY
- •PREOPERATIVE MEDICATIONS
- •OPERATIVE CARE
- •THE OPERATING ROOM
- •ANESTHESIA
- •EQUIPMENT
- •POSTOPERATIVE CARE
- •ACTIVITY
- •MEDICATIONS
- •REFERENCES
- •Glaucoma outflow procedures
- •GENERAL CONSIDERATIONS
- •EXTERNAL FILTRATION SURGERY
- •GUARDED PROCEDURES
- •FULL-THICKNESS PROCEDURES
- •RESULTS OF EXTERNAL FILTRATION SURGERY
- •THE CONJUNCTIVAL FLAP
- •LIMBUS-BASED FLAP
- •FORNIX-BASED FLAP
- •EXCISION OF TENON’S CAPSULE
- •GUARDED FILTRATION PROCEDURE
- •TRABECULECTOMY
- •Indications
- •Standard technique
- •Moorfields Safer Surgery System technique
- •Results
- •Surgical options and modifications
- •Triangular versus rectangular flap
- •Postoperative lasering, adjustment, or release of sutures
- •Wound-healing retardants
- •FULL-THICKNESS FILTRATION PROCEDURES
- •THERMAL SCLEROSTOMY (SCHEIE PROCEDURE)
- •SCLERECTOMY
- •Posterior lip sclerectomy
- •Anterior lip sclerectomy
- •TREPHINATION
- •IRIDENCLEISIS
- •GLAUCOMA DRAINAGE DEVICES
- •THE MOLTENO IMPLANT
- •Techniques
- •SCHOCKET PROCEDURE
- •KRUPIN VALVE AND EX-PRESS IMPLANT
- •AHMED VALVE
- •BAERVELDT IMPLANT
- •RESULTS AND COMPLICATIONS OF DRAINAGE DEVICES
- •REFERENCES
- •CATARACT SURGERY IN THE GLAUCOMATOUS EYE
- •TYPES OF GLAUCOMA AND THEIR INFLUENCE ON CATARACT MANAGEMENT
- •SELECTING THE APPROPRIATE SURGICAL APPROACH
- •SELECTING THE APPROPRIATE PROCEDURE: HISTORICAL CONSIDERATIONS
- •SURGICAL TECHNIQUES FOR COMBINED PROCEDURES
- •GENERAL PREOPERATIVE CONSIDERATIONS
- •SMALL-INCISION COMBINED SURGERY
- •Incision sites
- •Fornix versus limbal conjunctival flap
- •Scleral flap
- •Antimetabolite use
- •Managing the small pupil
- •Phacoemulsification techniques
- •Intraocular lens selection
- •Trabeculectomy formation
- •Flap closure
- •Postoperative medical management
- •EXTRACAPSULAR CATARACT EXTRACTION COMBINED SURGERY
- •Miotic pupil
- •Incision construction
- •CATARACT SURGERY WITH PRE-EXISTING FILTRATION BLEB
- •REFERENCES
- •BUTTONHOLING THE CONJUNCTIVA
- •THE SHALLOW AND FLAT ANTERIOR CHAMBER
- •FLAT ANTERIOR CHAMBER WITH HYPOTONY
- •FLAT ANTERIOR CHAMBER IN NORMOTENSIVE AND HYPERTENSIVE EYES
- •CILIARY BLOCK (MALIGNANT GLAUCOMA)
- •SUPRACHOROIDAL HEMORRHAGE (SCH)
- •INTRAOPERATIVE FLAT ANTERIOR CHAMBER
- •HYPHEMA
- •LARGE HYPHEMA
- •INTRAOCULAR INFECTION
- •SYMPATHETIC OPHTHALMIA
- •FILTRATION FAILURE
- •DIGITAL PRESSURE
- •FAILURE DURING THE FIRST POSTOPERATIVE WEEK
- •PLUGGED SCLEROSTOMY SITE
- •RETAINED VISCOELASTIC MATERIAL
- •TIGHT SCLERAL FLAP: RELEASABLE SUTURES AND LASER SUTURE LYSIS
- •INADEQUATE OPENING OF DESCEMET’S MEMBRANE
- •ENCAPSULATED BLEB
- •REOPERATION AFTER FAILED FILTRATION
- •REVISION OF ENCYSTED BLEB
- •Needling of failed blebs
- •Slit-lamp or minor surgery setting
- •Operating room setting
- •FAILED FILTRATION WITH NO BLEB
- •BLEB COMPLICATIONS AND MANAGEMENT
- •THIN-WALLED BLEBS
- •DIFFUSE BLEBS
- •OVERFUNCTIONING BLEBS
- •DELLEN
- •HYPOTONOUS MACULOPATHY
- •LATE HYPOTONY AFTER FILTERING SURGERY
- •HYPOTONY WITH OCCULT FILTERING ‘BLEB’
- •HYPOTONY WITH OCCULT CYCLODIALYSIS CLEFTS
- •HYPOTONY WITH AQUEOUS SUPPRESSION THERAPY IN CONTRALATERAL EYE
- •HYPOTONY FROM RETINAL DETACHMENT
- •HYPOTONY FROM IRITIS OR ISCHEMIA
- •REFERENCES
- •SURGERY FOR INFANTILE AND JUVENILE GLAUCOMA
- •GONIOTOMY
- •Preoperative considerations
- •Intraoperative procedures
- •Complications
- •Practice goniotomy
- •Other ab-interno angle surgery
- •TRABECULOTOMY AB EXTERNO
- •EVALUATION OF GONIOTOMY AND TRABECULOTOMY
- •COMBINED TRABECULOTOMY AND TRABECULECTOMY
- •TRABECULODIALYSIS
- •MISCELLANEOUS PROCEDURES
- •Goniosynechialysis
- •Cyclocryotherapy
- •Retrobulbar alcohol injection
- •Earlier procedures
- •REFERENCES
- •New ideas in glaucoma surgery
- •INTRODUCTION
- •NON-PENETRATING GLAUCOMA SURGERY
- •VISCOCANALOSTOMY
- •BYPASS INTRASCLERAL CHANNELS (NON-PENETRATING DEEP SCLERECTOMY)
- •SHUNTS INTO SCHLEMM’S CANAL
- •TRABECTOME®
- •SHUNTS INTO THE SUPRACHOROIDAL SPACE
- •SUMMARY
- •REFERENCES
- •Challenges for the new century
- •PATHOPHYSIOLOGY
- •CLASSIFICATION AND DIAGNOSIS
- •SCREENING
- •TREATMENT
- •CONCLUSION
- •REFERENCES
- •Appendix
- •GLAUCOMA CONSENSUS
- •GLAUCOMA DIAGNOSIS – STRUCTURE AND FUNCTION (2004)
- •CONSENSUS STATEMENTS
- •Structure
- •Function
- •Function and structure
- •GLAUCOMA SURGERY – OPEN ANGLE GLAUCOMA (2005)
- •CONSENSUS STATEMENTS
- •Indications for glaucoma surgery
- •Argon laser trabeculoplasty
- •Wound healing
- •Trabeculectomy
- •Combined cataract/trabeculectomy
- •Aqueous shunting procedures with glaucoma drainage devices
- •Comparison of procedures: trabeculectomy versus aqueous shunting procedures with glaucoma drainage devices
- •Non-penetrating glaucoma drainage surgery
- •Comparison of trabeculectomy with non-penetrating drainage glaucoma surgery in open-angle glaucoma
- •Cyclodestruction
- •Comparison of cyclophotocoagulation and glaucoma drainage device implantation
- •ANGLE CLOSURE AND ANGLE-CLOSURE GLAUCOMA (2006)
- •CONSENSUS STATEMENTS
- •Management of acute angle closure crisis
- •Surgical management of primary angle-closure glaucoma
- •Laser and medical treatment of primary angle-closure glaucoma
- •Laser and medical treatment of primary angle-closure glaucoma
- •Detection of primary angle closure and angle-closure glaucoma
- •INTRAOCULAR PRESSURE (2007)
- •CONSENSUS STATEMENTS
- •Measurement of intraocular pressure
- •Intraocular pressure as a risk factor for glaucoma development & progression
- •Epidemiology of intraocular pressure
- •Clinical trials and intraocular pressure
- •Target intraocular pressure in clinical practice
- •Index
|
chapter |
Intraocular pressure |
4 |
|
|
Unfortunately, the skewed distribution also means that an abnormal IOP must be defined empirically – that is, an abnormal pressure is one that causes optic nerve damage in a particular eye. Because eyes differ markedly in their susceptibility to the effects of pressure, it is difficult to know a priori what level of IOP will be harmful to a given patient. Some individuals develop glaucomatous damage at IOPs near the population mean, whereas others maintain normal optic nerves and visual function for many years despite IOPs of 30 or even 40 mmHg.
Similar mean IOPs are found using applanation and Schiøtz tonometry (see Table 4-1). Given the theoretic and practical shortcomings of Schiøtz tonometry, this suggests some combination of compensating errors for the indentation technique.
As a general rule, IOPs are similar in the right and left eyes of normal individuals. Although differences of 4 mmHg or more
between the eyes are seen in less than 4% of normal individuals,189,190 such differences are common in patients with glaucoma.
Davanger189 reported that 10% of patients with glaucoma had pressure differences greater than 6 mmHg. Lee and co-workers found in a population cross-sectional study that IOP asymmetry between the two eyes of the same older patient was often associated with undiagnosed glaucoma, whether the IOP was more than or less than 21 mmHg.191
Elevated IOP or the presence of glaucoma are associated with a decreased life expectancy according to the Framingham Eye Study.192 This association still persists even after the data are corrected for the usual factors associated with decreased life expectancy, such as age, gender, body mass, smoking, diabetes, and hypertension.
Factors that influence intraocular pressure
Many different factors affect IOP (Table 4-3). A few of the more important factors are discussed here.
Age
Most studies find a positive correlation between IOP and age.181,193–195 The effect of increasing age on IOP is the result, at
least in part, of increased blood pressure, increased pulse rate, and obesity.196,197 The Barbados Eye Study showed that the highest
correlations with IOP were age, systemic hypertension, and history of diabetes but female gender, larger body mass index, darker complexion, and positive family history of glaucoma.198 Except for age and positive family history, these correlations did not hold for actual glaucoma. It is unclear whether the rise in IOP with age represents an increase for all individuals or a greater skewness of the data – that is, a greater minority of the people having higher pressure while the majority show no change. One careful study of aqueous dynamics in normal subjects covering two different age groups showed a reduction in aqueous production as well as a reduction in uveoscleral outflow with age.199 It should be pointed
out that a number of studies find little correlation between IOP and age.197,200 In addition, one investigative team found that IOP declined with age in a group of Japanese workers.201,202 This trend
of decreasing IOP with age in normal Japanese eyes was confirmed
Table 4-3 Factors influencing intraocular pressure
Factors |
Association |
Comments |
|
|
|
Demographic |
|
|
|
|
|
Age |
Mean IOP increases with increasing age |
May be mediated partially through |
|
|
cardiovascular factors |
Sex |
Higher IOP in women |
Effect more marked after age 40 years |
Race |
Higher IOP among blacks |
|
Heredity |
IOP inherited |
Polygenic effect |
|
|
|
Systemic |
|
|
|
|
|
Diurnal variation |
Most people have a diurnal pattern of IOP |
Quite variable in some individuals |
Seasonal variation |
Higher IOP in winter months |
|
Blood pressure |
IOP increases with increasing blood pressure |
|
Obesity |
Higher IOP in obese people |
|
Posture |
IOP increases from sitting to inverted position |
Greater effect below horizontal |
Exercise |
Strenuous exercise lowers IOP transiently |
Long-term training has a lesser effect |
Neural |
Cholinergic and adrenergic input alters IOP |
|
Hormones |
Corticosteroids raise IOP; diabetes associated with increased IOP |
|
Drugs |
Multiple drugs alter IOP |
|
|
|
|
Ocular |
|
|
|
|
|
Refractive error |
Myopic individuals have higher IOP |
IOP correlates with axial length |
Eye movements |
IOP increases if eye moves against resistance |
|
Eyelid closure |
IOP increases with forcible closure |
|
Inflammation |
IOP decreases unless aqueous humor outflow affected more |
|
|
than inflow |
|
Surgery |
IOP generally decreases unless aqueous humor outflow affected |
|
|
more than inflow |
|
59
part
2 Aqueous humor dynamics
in a 10-year longitudinal study.203 In a study of Koreans, IOP also declined with age but increased with body mass index.204 In one important and interesting study that included both longitudinal follow-up as well as cross-sectional data in 70 000 Japanese subjects, IOP declined with age when looking at the cross-sectional data but actually increased with age in the longitudinal data.205 This suggests that some differences in IOP exist between different age groups that can not be explained by chronologic aging.
Sex
It has been reported that women have higher IOPs than men, especially after age 40.181 However, this finding was not confirmed in another study.206 The Barbados Eye Study showed that women were more likely to have high IOP without glaucoma damage and men were more likely to have open-angle glaucoma.207
Race
In the United States, blacks have higher IOPs than whites.194,208,209 In part, this difference appears to be racial or genetic. There is one report that the Zuni Indians of New Mexico have relatively low IOPs.210 It is unclear whether this phenomenon is caused by genetic or environmental factors. Because the definitions of, and differences between, various racial and ethnic groups are increasingly indistinct, it is difficult to predict the ultimate clinical utility of these observations.
Heredity
There appears to be a hereditary influence on IOP,181,211,212 which is polygenic in nature.210,213 A number of studies have indicated
that first-degree relatives of patients with open-angle glaucoma have higher IOPs than the general population.181,214 In contrast,
one study found that spouses have similar levels of IOP, which suggests that there are important environmental influences as well.215
Diurnal variation
Over the course of the day, IOP varies an average of 3–6 mmHg in normal individuals.216–223 Patients with glaucoma have much wider
swings of IOP that can reach 30 mmHg or even 50 mmHg in rare cases.216,218,221,224 In many people the diurnal variation of IOP fol-
lows a reproducible pattern, with the maximum pressure in the midmorning hours and the minimum pressure late at night or early in
the morning. However, some individuals peak in the afternoon or evening, and others follow no consistent pattern.221,224–228 In general,
normal, open-angle glaucoma and normal-pressure glaucoma patients have their peak in the morning with the nadir in the afternoon.229 One study suggests that any male with a borderline IOP measured midday should have a repeat measurement early in the morning, as males, in particular, may have wider diurnal swings.230 In general, the
two eyes show similar diurnal curves but there is a significant difference in how the right and left eye vary in their IOP.231
Many patients have a nocturnal surge in IOP.This increase in IOP is only partly explained by postural changes.232,233 Furthermore, this
same group showed that the pressure elevation is most likely towards the end of the dark cycle whenever in the real circadian cycle it occurs. However, short bursts of moderate light during the dark cycle had no effect on the nocturnal pressure elevation.234 Aging subjects also seem to have a relative elevation of IOP toward the
end of the dark cycle although most of it may be related to the supine recumbent position.235
Most of the diurnal pressure variation is caused by fluctuations in the rate of aqueous humor formation. There has been controversy about whether there are also diurnal variations in the facil-
ity of aqueous humor outflow, but recent studies indicate that this effect is small at most.224,229,236–240 The rate of aqueous formation
falls to low levels during sleep and increases during the day, most likely in response to circulating catecholamines.241,242 The decrease in aqueous flow during sleep is not as pronounced in untreated primary open-angle glaucoma patients as in normal controls, but the magnitude of the difference is so small that clinical relevance is unlikely.243 A few investigators have postulated that the diurnal IOP variation follows the diurnal glucocorticoid cycle, with IOP peaking about 3–4 hours after plasma cortisol.244
The diurnal variation in IOP has extremely important clinical implications for glaucoma patients. Asrani et al have shown that large diurnal variation in IOP is a risk factor for progression of glaucoma.245 Others have shown that the diurnal IOP curve is altered in glaucoma patients compared to normal subjects.246
The fact that the pressure can vary dramatically during a given day makes it unreasonable to assume that a single pressure taken at a specific time is representative of the average pressure the patient experiences over time. It is quite possible that this single pressure
represents a high or low point, and that the patient’s average pressures are substantially different.223,247 This is of particular concern
in patients with normal-tension glaucoma, in whom it may be
important to know whether the pressures are always in the low/ normal range, or if they sail into the 20 s every evening.248,249 A full
24-hour diurnal curve measurement is often prohibitively difficult to arrange in today’s climate of cost containment.A modified diurnal curve is much more practical, while still providing useful information. It is often fairly easy to measure an ‘office diurnal curve,’ which generally means checking the pressure every 1 or 2 hours from about 8 a.m. to 6 p.m. Pressure swings of 6 or 8 mmHg are not uncommon.222 Knowing the patient’s daily pressure excursions allows the physician to tailor therapy toward blunting peaks in pressure, as well as controlling the average pressure during a certain time of day.250 Jonas and co-workers estimated that a single a.m. in-office IOP measurement has about a 75% chance of missing the diurnal IOP maximum, and they recommend that the patient’s fol- low-up visits can be scheduled at differing times of the day to try and capture the maximum.251 This group has also suggested that it is the level of IOP itself, not the magnitude of fluctuations, that actually is responsible for continued optic nerve damage.252
Home tonometry has been suggested as a method of following patients’ pressures away from the office. It is unclear whether this method is practical in large populations, although it has been a successful adjunct in certain circumstances.253
Seasonal variation
A seasonal variation of IOP has been reported, with higher IOPs in the winter months.196,228,254–256 This phenomenon has been attrib-
uted to changes in the number of hours of light and to alterations of atmospheric pressure.255
Cardiovascular factors
A number of studies have shown a correlation between IOP and systemic blood pressure.194,196,197,206,214,257,258 The relationship is
60
|
chapter |
Intraocular pressure |
4 |
|
|
such that large changes in blood pressure are accompanied by small changes in IOP. For example, Bulpitt and co-workers have estimated that systemic blood pressure must rise by 100 mmHg to increase IOP by 2 mmHg.206 Normally, IOP fluctuates 1–3 mmHg as arte-
rial pressure varies with each cardiac cycle.259 The magnitude of this IOP fluctuation is related to the height of the ocular pressure259,260
and to the variation of arterial pressure. Systemic hypertension and glaucoma show only a modest association, and the bulk of the effect is attributable to perfusion pressure or other vascular effects, rather than increased IOP.261 Slower changes in IOP are seen with the Traube-Hering waves. A few researchers believe that IOP also correlates with pulse rate and hemoglobin concentration.197
Elevations of episcleral venous pressure, whether from local or systemic conditions, are associated with increased IOP. The rise in IOP is usually in the same range as the rise in episcleral venous pressure.
Alterations in serum osmolality produce changes in IOP. This is
best exemplified by the marked changes in IOP that occur during hemodialysis.262–264 Hyperosmotic drugs such as glycerine, urea,
and mannitol are administered systemically to reduce IOP during acute episodes of glaucoma.
Exercise
Strenuous exercise produces a transient reduction of IOP.265–270
This phenomenon is at least in part caused by acidosis and alterations in serum osmolality.266,270 In one study, a program of condi-
tioning reduced baseline IOP in normal volunteers.271 In general, those who are more physically fit are more likely to have a lower resting IOP.272 However, in extremely heavy exercise involving straining, such as weight lifting, IOP can be elevated significantly, perhaps due to valsalva or even increased intracranial pressure that is transmitted to the periocular venous system.273 In addition, holding one’s breath during weight lifting further increases the IOP.274
Wind instrument playing
Playing a wind instrument can raise the IOP, even in ophthalmologically normal individuals.275 The rise in IOP is higher with high-resistance instruments.276 Those musicians with large numbers of playing hours on high-resistance wind instruments are more likely to have optic nerve damage or visual field loss than their low-resistance colleagues.276
Lifestyle
Increased IOP was associated with increasing body mass index, increasing alcohol consumption and increasing cigarette consumption in one Japanese study.277 The Blue Mountain Eye Study also showed a modest correlation between smoking and IOP.278 Another result of the Blue Mountain Eye Study is that there is a positive correlation between caffeine consumption and level of IOP.279 In the Barbados Eye Study, systemic hypertension and diabetes were associated with increasing IOP with age.280 The Tanjong Eye Study suggested that lower socioeconomic status is associated with increasing IOP.281
Postural changes
When normal individuals go from the sitting to the supine position, IOP rises by as much as 6 mmHg.282–289 An even greater response
is seen in patients with open-angle glaucoma or normal-tension glaucoma.282,285–287,290,291 When normal volunteers are placed in
an inverted position, IOP increases markedly – that is, from an average of 16.8 mmHg to 32.9 mmHg in one study.292 Once again, the rise is greater in glaucomatous eyes.293 The increase in IOP occurs very rapidly and probably reflects changes in arterial and venous pressure.283 The episcleral venous pressure does increase in the supine position, at least partly accounting for the increase in IOP when lying down.294 However, postural changes in venous pressure cannot explain all of the IOP change since there is a difference between supine and prone IOPs.295 Brief elevations of IOP are unlikely to be dangerous in normal individuals, but they may be harmful in patients with advanced glaucoma.289
Postural changes in IOP become a problem when one depends on an examination under anesthesia to determine IOP in children or those developmentally challenged. The anesthesia reduces IOP (see below) but the act of placing the patient supine increases the IOP. Furthermore, positioning on the table, straight,Trendelenburg or reverse Trendelenburg will affect the IOP – with Trendelenburg causing an increase in IOP and the reverse Trendelenburg a decrease. All these factors have to be melded into interpreting the measurement.
Neural factors
A number of investigators have postulated that IOP is under neural control. As of yet there is no proof for this hypothesis, although some interesting observations have been made. Sympathectomy
produces a transient reduction in IOP and an increase in outflow facility from a release of catecholamines.296,297 In a similar fashion,
adrenergic agonists and cyclic adenosine monophosphate are capable of reducing IOP. 298–300
Other investigators have explored neural control of IOP by the parasympathetic system. Stimulation of the third cranial nerve reduces IOP.301 Cholinergic drugs lower IOP by increasing outflow facility. Conversely, ganglionic blocking drugs increase IOP.302 Finally, other investigators have sought central nervous system centers that might control IOP. Some researchers have found that
stimulation of specific diencephalic areas in experimental animals alters IOP, whereas other researchers303,304 believed these effects
were non-specific in nature. The third ventricle is close to the hypothalamus and other diencephalic centers. Infusion of a number of substances – including calcium, prostaglandins, arachidonic acid,
cyclic nucleotides, hyperosmotic solutions, and hypo-osmotic solutions – alters IOP.305–307
Changes in IOP seem to mirror changes in intracranial and cerebrospinal fluid pressure and some have suggested that IOP could be used as a marker for increased or decreased intracranial pressure in patients with known intracranial pathology.308
Psychiatric disorders
Ocular self-mutilation is a rare finding in psychotic and other severely disturbed patients.309–313 The authors have seen one
young man who pressed and rubbed his fists against his eyes continually unless he was heavily medicated or physically restrained. At the time of our examination his vision was 20/200 in his better eye, with no light perception in the worse eye. Both eyes showed extensive cupping typical of glaucomatous damage, although his pressures were entirely normal and he exhibited no other risk factors for glaucoma.
61
part
2 Aqueous humor dynamics
Hormonal factors
As mentioned previously, the diurnal intraocular fluctuation may follow the glucocorticoid cycle.244 Administration of corticosteroids topically, periocularly, and systemically raises IOP.
Some researchers have questioned whether sex hormones have
an influence on IOP. It has been noted that IOP varies with the menstrual cycle314–316 and is low in the third trimester of pregnancy.314,316,317 However, other studies have not found good cor-
relations between IOP and serum levels of progesterone and estrogen.318,319 Pharmacologic doses of progesterones and estrogens reduced IOP in experimental animals and man.316 Hormone replacement therapy in women has no effect on IOP;320 however, esterified estrogens with methyltestosterone therapy does raise IOP.321
Diabetic individuals have higher IOPs than the general population.The reason for this association is unclear.A careful populationbased study found that diabetic patients did not have an increased prevalence of glaucoma when selection bias was ruled out.322
Other hormones, including growth hormone, thyroxine (levothyroxine), aldosterone, vasopressin, and melanocyte-stimulating hormone, may influence IOP physiologically or when administered in pharmacologic doses.323
Refractive error
A number of studies have reported higher IOPs in myopic individuals.214,324,325 Intraocular pressure also correlates with axial
length.326 This has been reported in several studies involving pedi-
atric patients, with some investigators suggesting that the increased pressure leads to the increase in axial length.327–329 However, not
all studies in children are able to confirm this association.330
Foods and drugs
A variety of foods and drugs can alter IOP transiently (Table 4 4). Topical cycloplegic agents as well as systemic agents that have cholinergic effects can raise the IOP.339 Occasionally, longer acting cycloplegics like cyclopentolate can cause prolonged and serious
pressure rises in glaucoma patients; such significant pressure rises
are quite rare in eyes free from glaucoma.340 Anesthetic and sedative agents will lower IOP.341,342 The effect of general anesthesia is com-
pounded by the fact that IOP is elevated during the excitatory phase and becomes progressively lower as the anesthesia lasts longer and phases of anesthesia become deeper. Therefore, timing of measurement following induction of general anesthesia is important. If one measures too early, you may be in the excitatory phase and erroneously read a pressure that is higher than resting pressure. If one measures later, the IOP may be lower than resting IOP due to the effects of deeper anesthesia plane or longer duration of anesthesia.
Miscellaneous
Significant spontaneous asymmetric fluctuations do occur among both normal subjects and glaucoma patients; such fluctuations may cause trouble in interpreting one-eyed studies as well as interpreting therapeutic interventions.343 Forced eyelid closure can cause a significant increase in IOP and attempted squeezing of the eyelids
during tonometry can be a significant source of error with either the Goldmann tonometer or the Tono-Pen.344,345 Just the place-
ment of an eyelid speculum, even in a child fully induced with general anesthesia, can raise the IOP by about 4 mmHg.346 A tight
necktie can significantly raise IOP in glaucoma patients and possibly in normal subjects;347,348 this can have some important impli-
cations for glaucoma management, although prolonged use of a tight necktie may produce adaptive reflexes that return the eye to its pre-tight necktie level.349 Nevertheless, it seems reasonable to caution glaucoma patients not to wear tight neckties.
The Blue Mountain Eye Study showed a small but significant correlation between increasing iris pigmentation and IOP level.350 Intraocular pressure is reduced at extremely high altitudes and returns to resting levels upon descent.351
Eye movements
If the eye moves against mechanical resistance, IOP can rise substantially.352–355
Table 4-4 Food and drugs influencing intraocular pressure
Agent |
Association |
Comments |
|
|
|
General |
IOP is reduced in |
Exceptions are |
anesthesia331 |
proportion to depth |
ketamine and |
Alcohol335,336 |
of anesthesia |
trichlorethylene332–334 |
Reduces IOP |
Acts through inhibition of |
|
|
|
antidiuretic hormone |
|
|
and reduction of |
|
|
aqueous formation335 |
Marijuana |
Reduces IOP |
Acts through local, |
|
|
vascular, and central |
|
|
effects |
Corticosteroids |
Raise IOP |
Effect greater on |
Topical cycloplegic |
Raise IOP |
glaucomatous eyes |
|
||
agents337,338 |
|
|
Water |
Raises IOP |
Large volumes of fluid |
|
|
( 500 ml) can raise |
|
|
IOP |
Eyelid closure
Forcible eyelid closure raises IOP by 10–90 mmHg.356 Repeated eyelid squeezing reduces IOP.357 Widening of the lid fissure
increases IOP by approximately 2 mmHg.358 Conversely, with Bell’s palsy, IOP is slightly reduced.359,360
Inflammation
Intraocular pressure is usually reduced when the eye is inflamed because aqueous humor formation is reduced. However, if the outflow channels are more affected than the ciliary body, IOP can be elevated.
Surgery
In most cases, IOP is reduced after ocular surgery. However, if the outflow channels are affected by inflammation or by the surgery itself (e.g., by viscoelastic substances or by an incision that reduces support for the trabecular meshwork), IOP can be elevated.361 Trabeculectomy seems more effective at controlling IOP over the 24-hour period than maximal medical therapy.362
62
